Paula S. Fidalgo

Santo Antonio De Felheiros, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Objective measurement of physical activity levels and patient-reported outcomes in cancer patients receiving immune-checkpoint inhibitors: a cross-sectional study.

Objective measurement of physical activity levels and patient-reported outcomes in cancer patients receiving immune-checkpoint inhibitors: a cross-sectional study.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: January 12, 2025

Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University Center.

Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University Center.

Journal: Current oncology (Toronto, Ont.)

Published: January 05, 2024

Lung Cancer Screening in Portugal: A PULMONALE Pilot Project

Lung Cancer Screening in Portugal: A PULMONALE Pilot Project

Journal: Acta medica portuguesa

Published: September 25, 2023

Liquid biopsy in the management of advanced lung cancer: Implementation and practical aspects.

Liquid biopsy in the management of advanced lung cancer: Implementation and practical aspects.

Journal: Cancer treatment and research communications

Published: March 13, 2023

Impact of Immune-Related Adverse Events on Immune Checkpoint Inhibitors Treated Cancer Patients' Survival: Single Center Experience and Literature Review.

Impact of Immune-Related Adverse Events on Immune Checkpoint Inhibitors Treated Cancer Patients' Survival: Single Center Experience and Literature Review.

Journal: Cancers

Published: December 12, 2022

Chemotherapy: A partnership with immunotherapy in non-small cell lung cancer.

Chemotherapy: A partnership with immunotherapy in non-small cell lung cancer.

Journal: Thoracic cancer

Published: November 16, 2022

Improving non-small-cell lung cancer survival through molecular characterization: Perspective of a multidisciplinary expert panel.

Improving non-small-cell lung cancer survival through molecular characterization: Perspective of a multidisciplinary expert panel.

Journal: Pulmonology

Published: September 20, 2022

Limitations and perceived delays for diagnosis and staging of lung cancer in Portugal: A nationwide survey analysis.

Limitations and perceived delays for diagnosis and staging of lung cancer in Portugal: A nationwide survey analysis.

Journal: PloS one

Published: February 25, 2021

Residential Radon and Small Cell Lung Cancer. Final Results of the Small Cell Study.

Residential Radon and Small Cell Lung Cancer. Final Results of the Small Cell Study.

Journal: Archivos de bronconeumologia

Published: December 03, 2020

Residential Radon and Small Cell Lung Cancer. Final Results of the Small Cell Study.

Residential Radon and Small Cell Lung Cancer. Final Results of the Small Cell Study.

Journal: Archivos de bronconeumologia

Published: December 03, 2020

Real-world data from the Portuguese Nivolumab Expanded Access Program (EAP) in previously treated Non Small Cell Lung Cancer (NSCLC).

Real-world data from the Portuguese Nivolumab Expanded Access Program (EAP) in previously treated Non Small Cell Lung Cancer (NSCLC).

Journal: Pulmonology

Published: February 26, 2019

Acute kidney injury in an internal medicine ward in a Portuguese quaternary hospital.

Acute kidney injury in an internal medicine ward in a Portuguese quaternary hospital.

Journal: European journal of internal medicine

Published: October 27, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026